Mielodiszplasztikus szindróma (MDS): vizsgálatok itt: Csehország
7 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 2. fázisNot yet taking people in CsehországBexmarilimab + Azacitidine Versus Placebo + Azacitidine in Participants With Treatment-naïve Higher-risk Myelodysplastic Syndromes
- Where
- Brno, Hradec Králové, Ostrava, Prague
- Életkor
- 18 év and over
- People
- 90 worldwide
- Run by
- Faron Pharmaceuticals Ltd
See details and how to joinNCT07672769 · EU 2026-526706-33-00 - 3. fázisTaking peopleA Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
- Where
- Brno, Novy Hradec Kralove, Ostrava, Prague, Prague 2
- Életkor
- 18 év and over
- People
- 225 worldwide
- Run by
- Takeda
See details and how to joinNCT06499285 · EU 2024-516009-22-00 - 2. fázisFut, nem toborozA Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)
- Where
- Prague
- Életkor
- 18 év and over
- People
- 210 worldwide
- Run by
- Takeda
See details and how to joinNCT04419649 · EU 2023-507469-24-00 - No phaseTaking peopleEarly Detection and Screening of Hematological Malignancies - SANGUINE
- Where
- Olomouc
- Életkor
- 18 év and over
- People
- 3000 worldwide
- Run by
- JaxBio Ltd
See details and how to joinNCT05735704 - 3. fázisTaking peopleLisaftoclax (APG-2575) Combined With Azacytidine (AZA) in the Treatment of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4).
- Where
- Brno, Hradec Králové, Ostrava, Prague 2
- Életkor
- 18 év and over
- People
- 490 worldwide
- Run by
- Ascentage Pharma Group Inc.
See details and how to joinNCT06641414 · EU 2024-517247-31-00 - 2/3. fázisTaking peopleA Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
- Where
- Brno, Ostrava, Prague, Prague 2
- Életkor
- 18 év and over
- People
- 316 worldwide
- Run by
- Taiho Oncology, Inc.
See details and how to joinNCT04256317 · EU 2024-515098-93-00 - 1/2. fázisTaking peopleProton-Based Total Marrow Irradiation for Allogeneic Transplantation in High-Risk AML/MDS
- Where
- Prague
- Életkor
- 18 év to 65 év
- People
- 16
- Run by
- Institute of Hematology and Blood Transfusion, Czech Republic
See details and how to joinNCT07532824